Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.
Journal
Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086
Informations de publication
Date de publication:
13 01 2021
13 01 2021
Historique:
received:
22
07
2020
revised:
04
10
2020
accepted:
30
11
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
13
7
2021
Statut:
ppublish
Résumé
Type 1 interferons (IFN-I) are potent innate antiviral effectors that constrain HIV-1 transmission. However, harnessing these cytokines for HIV-1 cure strategies has been hampered by an incomplete understanding of their antiviral activities at later stages of infection. Here, we characterized the IFN-I sensitivity of 500 clonally derived HIV-1 isolates from the plasma and CD4
Identifiants
pubmed: 33441429
pii: 13/576/eabd8179
doi: 10.1126/scitranslmed.abd8179
pmc: PMC7923595
mid: NIHMS1667384
pii:
doi:
Substances chimiques
Antiviral Agents
0
Interferon Type I
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : UM1 AI126620
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007632
Pays : United States
Organisme : Medical Research Council
ID : MR/K012037/1
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : UM1 AI126619
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114266
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI162646
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118549
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI129825
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI144371
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI100663
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI111789
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI045008
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI065279
Pays : United States
Organisme : NIAID NIH HHS
ID : R33 AI133696
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI160607
Pays : United States
Informations de copyright
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Références
Nat Rev Immunol. 2020 Aug;20(8):471-482
pubmed: 32051540
Immunol Rev. 2004 Dec;202:8-32
pubmed: 15546383
Curr Opin HIV AIDS. 2011 Sep;6(5):353-63
pubmed: 21734567
Immunity. 2019 Apr 16;50(4):907-923
pubmed: 30995506
J Infect Dis. 1995 Apr;171(4):822-8
pubmed: 7706808
Nat Med. 1997 Feb;3(2):205-11
pubmed: 9018240
AIDS. 2011 Jan 2;25(1):115-8
pubmed: 20962614
Curr Opin HIV AIDS. 2011 Sep;6(5):411-8
pubmed: 21743324
Retrovirology. 2013 Dec 03;10:146
pubmed: 24299076
Science. 2016 Jul 22;353(6297):aaf6517
pubmed: 27463679
Nature. 2011 Apr 28;472(7344):481-5
pubmed: 21478870
AIDS. 2010 Jun 19;24(10):1415-23
pubmed: 20495440
Cytokine. 2011 Jan;53(1):52-9
pubmed: 20943413
AIDS. 2018 Jul 31;32(12):1599-1611
pubmed: 29762170
Pathog Immun. 2016 Spring;1(1):107-116
pubmed: 27500281
J Exp Med. 2018 Sep 3;215(9):2311-2324
pubmed: 30072495
Cell. 2011 Aug 19;146(4):621-32
pubmed: 21854986
Sci Transl Med. 2019 Oct 9;11(513):
pubmed: 31597754
Lancet. 1999 Nov 20;354(9192):1782-5
pubmed: 10577640
Front Immunol. 2018 Jan 15;8:1823
pubmed: 29379496
J Infect Dis. 2019 Jul 2;220(220 Suppl 1):S5-S6
pubmed: 30779842
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Cell Rep. 2018 Oct 23;25(4):893-908.e7
pubmed: 30355496
Curr HIV/AIDS Rep. 2015 Mar;12(1):41-53
pubmed: 25662992
J Biol Chem. 2017 May 5;292(18):7285-7294
pubmed: 28289098
J Clin Invest. 2009 Dec;119(12):3544-55
pubmed: 19959873
Nature. 2018 Dec;564(7734):E8
pubmed: 30397346
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Nature. 2014 Jul 31;511(7511):601-5
pubmed: 25043006
Bioinformatics. 2006 May 1;22(9):1064-71
pubmed: 16488909
AIDS. 2012 Sep 24;26(15):1895-905
pubmed: 22842994
PLoS One. 2013;8(2):e56527
pubmed: 23437155
Cell Host Microbe. 2016 Oct 12;20(4):429-442
pubmed: 27640936
J Virol. 2008 Apr;82(8):3952-70
pubmed: 18256145
Ann Intern Med. 1992 Sep 15;117(6):457-60
pubmed: 1503348
Mucosal Immunol. 2016 Nov;9(6):1528-1536
pubmed: 26838048
J Immunol. 2009 Aug 15;183(4):2708-17
pubmed: 19625640
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):E7908-E7916
pubmed: 27872306
J Infect Dis. 2011 Dec 15;204(12):1927-35
pubmed: 22006994
Nat Rev Microbiol. 2015 Jul;13(7):403-13
pubmed: 25915633
J Infect Dis. 2010 Jun 1;201(11):1686-96
pubmed: 20420510
J Clin Invest. 2020 Jun 1;130(6):3299-3304
pubmed: 32182219
J Virol. 2010 Aug;84(15):7886-91
pubmed: 20484518
PLoS Pathog. 2009 Feb;5(2):e1000296
pubmed: 19214219
Lancet HIV. 2019 Apr;6(4):e259-e268
pubmed: 30885693
J Clin Invest. 2020 Jun 1;130(6):2845-2858
pubmed: 32017709
J Virol. 2018 Apr 13;92(9):
pubmed: 29467313
Immunity. 2003 Mar;18(3):441-52
pubmed: 12648460
Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E590-E599
pubmed: 28069935
J Virol. 2005 Oct;79(19):12164-72
pubmed: 16160143
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6626-33
pubmed: 23542380
J Exp Med. 2009 Jun 8;206(6):1253-72
pubmed: 19487423
Sci Transl Med. 2017 Mar 15;9(381):
pubmed: 28298420
N Engl J Med. 2016 Nov 24;375(21):2037-2050
pubmed: 27959728
Virol Sin. 2019 Apr;34(2):192-196
pubmed: 30762199
Cell. 2014 Jul 31;158(3):481-91
pubmed: 25065977
Curr Opin HIV AIDS. 2013 Mar;8(2):125-31
pubmed: 23380653
Science. 1996 Mar 15;271(5255):1582-6
pubmed: 8599114
Blood. 2005 Mar 15;105(6):2458-64
pubmed: 15585654
Cytokine Growth Factor Rev. 2016 Oct;31:83-90
pubmed: 27544015
J Virol. 2009 Apr;83(8):3719-33
pubmed: 19176632
PLoS Pathog. 2013;9(5):e1003398
pubmed: 23737751
J Virol. 2008 Feb;82(4):1870-83
pubmed: 18077723
Nature. 2003 Mar 20;422(6929):307-12
pubmed: 12646921
J Interferon Cytokine Res. 2008 Dec;28(12):749-63
pubmed: 18937549
Nature. 2009 Apr 23;458(7241):1034-8
pubmed: 19262509
Immunity. 2006 Sep;25(3):373-81
pubmed: 16979569
J Immunol. 2019 Aug 1;203(3):705-717
pubmed: 31253727
J Clin Invest. 2009 Dec;119(12):3556-72
pubmed: 19959874
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
PLoS Med. 2004 Dec;1(3):e64
pubmed: 15630469
J Virol. 2003 Apr;77(8):5037-8
pubmed: 12663814
J Clin Invest. 2017 Jan 3;127(1):269-279
pubmed: 27941247
J Immunol. 2009 Aug 1;183(3):1975-82
pubmed: 19596987
Nature. 2018 Sep;561(7724):479-484
pubmed: 30258136
J Clin Invest. 2018 Jul 2;128(7):3102-3115
pubmed: 29911997
Curr HIV/AIDS Rep. 2012 Jun;9(2):139-47
pubmed: 22528766
Nat Microbiol. 2019 Jun;4(6):914-924
pubmed: 30936491
J Infect Dis. 2013 Jan 15;207(2):213-22
pubmed: 23105144
AIDS. 2019 Jul 1;33(8):1315-1325
pubmed: 30932955
Front Immunol. 2019 Feb 26;10:291
pubmed: 30863403
J Exp Med. 2009 Jun 8;206(6):1273-89
pubmed: 19487424
PLoS Pathog. 2012;8(5):e1002721
pubmed: 22693447
J Infect Dis. 2020 Apr 27;221(10):1740-1742
pubmed: 31742347
Cytokine. 2011 Nov;56(2):282-9
pubmed: 21856167
J Clin Invest. 2017 Jan 3;127(1):260-268
pubmed: 27941243